Charles River Laboratories International CRL
NYSE CRL
$303.72 +4.70 (+1.57%)
As of: Oct 14, 2026 · 1:17 PM EDT

Charles River Laboratories International (CRL) Cash from Operations (2009 - 2026)

Updated

Charles River Laboratories International's Cash from Operations was $179.73 million in Q2 2026, down 12.2% from $204.6 million a year earlier but up 337.5% from the prior quarter.

Analysis

Charles River Laboratories International (CRL) Cash from Operations (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Charles River Laboratories International's Cash from Operations was $582.15 million through Jun 27, 2026, down 26.1% year-over-year; for FY2025, it came in at $737.65 million, up 0.4% from FY2024.

  • Cash from Operations has now increased for three consecutive years, with a five-year compound annual growth rate of 6.2% (FY2020 to FY2025).
  • In earlier years, Cash from Operations was $734.58 million in FY2024 (+7.4%), $683.9 million in FY2023 (+10.4%), $619.64 million in FY2022 (-18.6%) and $760.8 million in FY2021 (+39.2%).
  • Quarterly Cash from Operations has moved between $41.08 million (Q1 2026) and $251.79 million (Q3 2024) over five years.
  • Compared with a year earlier, Cash from Operations has declined for four straight quarters, with an average decline of 9.8% over the last eight quarters.
  • The best year-over-year quarter for Cash from Operations over five years was Q4 2021 (growth of 65.7%); the worst was Q1 2026 (a decline of 76.1%).
  • Per Business Quant data, CRL's Cash from Operations in the three quarters before Q2 2026 was $41.08 million (Q1 2026), $147.52 million (Q4 2025) and $213.83 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Iqvia Holdings 43.59 Bn 35.29 Bn 1.44 Bn 558.00 Mn
2 Medpace Holdings 17.33 Bn 15.40 Bn 201.64 Mn 162.01 Mn
3 Charles River Laboratories International 14.59 Bn 13.78 Bn 363.37 Mn 179.73 Mn
4 Icon 13.22 Bn 10.33 Bn 479.29 Mn 281.27 Mn
5 Fortrea Holdings 2.04 Bn 1.42 Bn 139.20 Mn 28.90 Mn
6 Ginkgo Bioworks Holdings 730.23 Mn -31.85 Mn 18.44 Mn -44.27 Mn
7 Evotec SE 502.55 Mn -1.11 Bn - -
8 Champions Oncology 67.61 Mn 42.70 Mn 7.70 Mn -492,000.00
9 MindWalk Holdings 65.40 Mn 29.05 Mn 1.61 Mn -2.90 Mn
10 Natural Alternatives International 6.57 Mn -21.51 Mn 1.73 Mn -1.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 179.73 Mn
Mar 28, 2026 41.08 Mn
Dec 27, 2025 147.52 Mn
Sep 27, 2025 213.83 Mn
Jun 28, 2025 204.60 Mn
Mar 29, 2025 171.70 Mn
Dec 28, 2024 159.36 Mn
Sep 28, 2024 251.79 Mn
Jun 29, 2024 193.54 Mn
Mar 30, 2024 129.89 Mn
Dec 30, 2023 220.94 Mn
Sep 30, 2023 205.45 Mn
Jul 1, 2023 148.12 Mn
Apr 1, 2023 109.38 Mn
Dec 31, 2022 234.76 Mn
Sep 24, 2022 132.78 Mn
Jun 25, 2022 149.47 Mn
Mar 26, 2022 102.63 Mn
Dec 25, 2021 229.26 Mn
Sep 25, 2021 174.72 Mn
API Access

Charles River Laboratories International Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=CRL&period=max&api_key=YOUR_API_KEY